Overview

One‑of‑a‑Kind Partnership
The Gene Therapy Initiative at UC San Diego, California Life Sciences and CIRM converge in La Jolla, CA – September 16 & 17 to discuss the Future of Cell & Gene Therapy.

All‑Encompassing Agendas

Day 1, hosted by UC San Diego GTI, features academic and industry leaders showcasing cutting‑edge cell‑based safety models, ex‑vivo and in‑vivo genetic therapy technologies, and bold bench‑to‑bedside strategies.
Day  2, hosted by CLS and CIRM, features panels on scientific innovation, manufacturing, patient delivery, and commercialization.

Tailored Flexibility
Each day stands on its own, so participants can choose to attend one or attend both. The program is built for everyone working in this space across Southern California, across therapeutics, manufacturing, research, capital, and the legal and policy infrastructure that supports the field.

Who Should Attend:

Academic researchers and post‑doctoral fellows in cell & gene therapy
Biotech and pharmaceutical scientists, project managers, and business development professionals
Investors, venture‑capital partners, entrepreneurs, and industry consultants
Regulatory affairs, quality & manufacturing specialists